Reportable segment operating profit
Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular | $1.20B | $1.13B | $1.16B | $1.21B | $500.00M | $828.00M | $877.00M | $899.00M |
| Neuroscience | $991.00M | $961.00M | $1.02B | $1.06B | $384.00M | $705.00M | $740.00M | $737.00M |
| Medical Surgical | $658.00M | $690.00M | $774.00M | $765.00M | $259.00M | $494.00M | $531.00M | $499.00M |
| Diabetes Group | $100.00M | $102.00M | $116.00M | $136.00M | -$57.00M | $26.00M | $53.00M | $57.00M |
| Other operating segment | — | — | — | $13.00M | $6.00M | $11.00M | $9.00M | -$1.00M |
| Total | $1.39B | $1.28B | $1.60B | $1.65B | $1.48B | $1.45B | $1.69B | $1.46B |
Segments
NeuroscienceView metric
Other operating segmentView metric
CardiovascularView metric
Medical SurgicalView metric
Diabetes GroupView metric